CymaBay Therapeutics, Inc. ( CBAY) - Stock Earnings
Stock symbol CBAY is outdated, potentially delisted? Maybe it is available on other exchange?
CBAY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -808000 USD | 31.0 million USD |
| 2023Q3 | -33.9 million USD | — USD |
| 2023Q4 | -41.9 million USD | 57000 USD |
CBAY Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -92.6 million USD | 0 USD |
| 2022 | -118.9 million USD | 31.0 million USD |
| 2023 | -105.4 million USD | 31.1 million USD |
CBAY
Price: $32.48
52 week price:
Earnings Per Share: -0.93 USD
P/E Ratio: -34.58
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 528000
Ebitda: -8.0 millionMarket Capitalization: 3.7 billion